PortfoliosLab logoPortfoliosLab logo
CI vs. CTAS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CI vs. CTAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cigna Corporation (CI) and Cintas Corporation (CTAS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CI achieves a 4.02% return, which is significantly higher than CTAS's -9.80% return. Over the past 10 years, CI has underperformed CTAS with an annualized return of 9.39%, while CTAS has yielded a comparatively higher 23.18% annualized return.


CI

1D
0.35%
1M
-0.53%
YTD
4.02%
6M
4.58%
1Y
-8.71%
3Y*
2.93%
5Y*
5.74%
10Y*
9.39%

CTAS

1D
-0.38%
1M
-2.39%
YTD
-9.80%
6M
-11.02%
1Y
-22.86%
3Y*
12.84%
5Y*
13.36%
10Y*
23.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CI vs. CTAS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CI
Cigna Corporation
4.02%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%
CTAS
Cintas Corporation
-9.80%3.78%22.24%34.82%2.97%26.51%32.74%61.73%9.04%36.32%

Correlation

The correlation between CI and CTAS is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Mar 26, 1990

0.28

The correlation between CI and CTAS shifts across timeframes, from 0.17 (1 year) to 0.30 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CI:

$74.74B

CTAS:

$68.67B

EPS

CI:

$23.59

CTAS:

$4.75

PE Ratio

CI:

12.00

CTAS:

35.51

PEG Ratio

CI:

0.69

CTAS:

2.49

PS Ratio

CI:

0.27

CTAS:

6.24

PB Ratio

CI:

1.77

CTAS:

14.34

Total Revenue (TTM)

CI:

$277.94B

CTAS:

$11.03B

Gross Profit (TTM)

CI:

$19.38B

CTAS:

$1.33B

EBITDA (TTM)

CI:

$10.03B

CTAS:

$2.66B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CI vs. CTAS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CI
CI Risk / Return Rank: 3030
Overall Rank
CI Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
CI Sortino Ratio Rank: 2929
Sortino Ratio Rank
CI Omega Ratio Rank: 2828
Omega Ratio Rank
CI Calmar Ratio Rank: 3131
Calmar Ratio Rank
CI Martin Ratio Rank: 3232
Martin Ratio Rank

CTAS
CTAS Risk / Return Rank: 77
Overall Rank
CTAS Sharpe Ratio Rank: 44
Sharpe Ratio Rank
CTAS Sortino Ratio Rank: 66
Sortino Ratio Rank
CTAS Omega Ratio Rank: 88
Omega Ratio Rank
CTAS Calmar Ratio Rank: 1010
Calmar Ratio Rank
CTAS Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CI vs. CTAS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Cintas Corporation (CTAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CICTASDifference
Sharpe ratioReturn per unit of total volatility

+0.84

Sortino ratioReturn per unit of downside risk

+1.36

Omega ratioGain probability vs. loss probability

0.98

0.83

+0.16

Calmar ratioReturn relative to maximum drawdown

-0.33

-0.84

+0.51

Martin ratioReturn relative to average drawdown

-0.59

-1.43

+0.84

CI vs. CTAS - Sharpe Ratio Comparison

The current CI Sharpe Ratio is -0.26, which is higher than the CTAS Sharpe Ratio of -1.10. The chart below compares the historical Sharpe Ratios of CI and CTAS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CI vs. CTAS - Drawdown Comparison

The maximum CI drawdown since its inception was -84.34%, which is greater than CTAS's maximum drawdown of -65.32%. Use the drawdown chart below to compare losses from any high point for CI and CTAS.


Loading charts...

Drawdown Indicators


CICTASDifference

Max Drawdown

Largest peak-to-trough decline

-84.34%

-65.32%

-19.02%

Max Drawdown (1Y)

Largest decline over 1 year

-26.54%

-27.23%

+0.69%

Max Drawdown (3Y)

Largest decline over 3 years

-32.10%

-27.68%

-4.42%

Max Drawdown (5Y)

Largest decline over 5 years

-32.10%

-27.68%

-4.42%

Max Drawdown (10Y)

Largest decline over 10 years

-42.47%

-48.38%

+5.91%

Current Drawdown

Current decline from peak

-20.02%

-25.15%

+5.13%

Average Drawdown

Average peak-to-trough decline

-18.82%

-15.04%

-3.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.71%

16.03%

-1.32%

Volatility

CI vs. CTAS - Volatility Comparison

The current volatility for Cigna Corporation (CI) is 8.10%, while Cintas Corporation (CTAS) has a volatility of 8.68%. This indicates that CI experiences smaller price fluctuations and is considered to be less risky than CTAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CICTASDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.10%

8.68%

-0.58%

Volatility (6M)

Calculated over the trailing 6-month period

18.89%

16.16%

+2.73%

Volatility (1Y)

Calculated over the trailing 1-year period

33.34%

20.81%

+12.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.44%

22.61%

+5.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.77%

26.74%

+4.03%

Dividends

CI vs. CTAS - Dividend Comparison

CI's dividend yield for the trailing twelve months is around 2.17%, more than CTAS's 1.07% yield.


PositionTTM20252024202320222021202020192018201720162015
CI
Cigna Corporation
2.17%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
CTAS
Cintas Corporation
1.07%0.89%0.80%0.83%0.93%0.77%0.99%0.95%1.22%1.04%1.15%1.15%

Financials

CI vs. CTAS - Financials Comparison

This section allows you to compare key financial metrics between Cigna Corporation and Cintas Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
68.49B
2.84B
(CI) Total Revenue
(CTAS) Total Revenue
Values in USD except per share items

CI vs. CTAS - Profitability Comparison

The chart below illustrates the profitability comparison between Cigna Corporation and Cintas Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%202220232024202520260
-97.8%
Portfolio components
CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a gross profit of 0.00 and revenue of 68.49B. Therefore, the gross margin over that period was 0.0%.

CTAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cintas Corporation reported a gross profit of -2.78B and revenue of 2.84B. Therefore, the gross margin over that period was -97.8%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported an operating income of 2.36B and revenue of 68.49B, resulting in an operating margin of 3.4%.

CTAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cintas Corporation reported an operating income of 659.90M and revenue of 2.84B, resulting in an operating margin of 23.2%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a net income of 1.65B and revenue of 68.49B, resulting in a net margin of 2.4%.

CTAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cintas Corporation reported a net income of 502.50M and revenue of 2.84B, resulting in a net margin of 17.7%.


Frequently Asked Questions


CI and CTAS have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CTAS has higher volatility (8.68%) compared to CI (8.10%). In terms of maximum drawdown, CI dropped -84.34% vs CTAS's -65.32%.

CI currently has the higher Sharpe Ratio (-0.26 vs -1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CI and CTAS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer